SANGAMO THERAPEUTICS, INC (SGMO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SGMO
See up to 3 months of SGMO. The 7-day demo opens the 1M and 3M ranges and puts SGMO on your watchlist.
Start 7-day demoLatest SGMO insider trades
Gregory D. Davis - OfficerOpen-market sale$18K- Nathalie Dubois-Stringfellow - OfficerOpen-market sale$89K
About SANGAMO THERAPEUTICS, INC (SGMO)
The SEC lists SANGAMO THERAPEUTICS, INC under CIK 0001001233, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
SGMO Form 4 activity by transaction type, last 90 days
No Form 4 activity for SGMO in the last 90 days.
SGMO insider transactions (Form 4)
3568 Form 4 filings on record, the earliest from Nov 26, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gregory D. Davis - Officer | Tax withholding / forfeiture | Common Stock | 1,630 footnote F1 | $0.17 | $284 | |
| ||||||
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 1,919 footnote F1 | $0.17 | $334 | |
| ||||||
| Nathalie Dubois-Stringfellow - Officer | Tax withholding / forfeiture | Common Stock | 4,036 footnote F1 | $0.17 | $703 | |
| ||||||
 Scott B. Willoughby - Officer | Tax withholding / forfeiture | Common Stock | 4,036 footnote F1 | $0.17 | $703 | |
| ||||||
 Sandy Macrae - Officer | Tax withholding / forfeiture | Common Stock | 12,613 footnote F1 | $0.17 | $2K | |
| ||||||
| Gregory D. Davis - Officer | Open-market sale | Common Stock | 69,827 | $0.25 footnote F1 | $18K | |
| ||||||
| Nathalie Dubois-Stringfellow - Officer | Open-market sale | Common Stock | 345,942 | $0.26 footnote F1 | $89K | |
| ||||||
| Nathalie Dubois-Stringfellow - Officer | Grant or award | Stock Option (Right to Buy) | 800,000 | $0.00 | - | |
| Nikunj Jain - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Gregory D. Davis - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Sandy Macrae - Officer | Grant or award | Stock Option (Right to Buy) | 2,500,000 | $0.00 | - | |
| Scott B. Willoughby - Officer | Grant or award | Stock Option (Right to Buy) | 800,000 | $0.00 | - | |
| Nathalie Dubois-Stringfellow - Officer | Tax withholding / forfeiture | Common Stock | 2,063 footnote F1 | $0.47 | $975 | |
| Nathalie Dubois-Stringfellow - Officer | Tax withholding / forfeiture | Common Stock | 12,354 footnote F3 | $0.47 | $6K | |
| ||||||
| Sandy Macrae - Officer | Tax withholding / forfeiture | Common Stock | 5,291 footnote F1 | $0.47 | $2K | |
| Sandy Macrae - Officer | Tax withholding / forfeiture | Common Stock | 33,637 footnote F3 | $0.47 | $16K | |
| ||||||
| Scott B. Willoughby - Officer | Tax withholding / forfeiture | Common Stock | 1,650 footnote F1 | $0.47 | $780 | |
| Scott B. Willoughby - Officer | Tax withholding / forfeiture | Common Stock | 12,354 footnote F3 | $0.47 | $6K | |
| ||||||
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 666 footnote F1 | $0.47 | $315 | |
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 5,119 footnote F3 | $0.47 | $2K | |
| ||||||
| Gregory D. Davis - Officer | Tax withholding / forfeiture | Common Stock | 832 footnote F1 | $0.47 | $393 | |
| Gregory D. Davis - Officer | Tax withholding / forfeiture | Common Stock | 5,119 footnote F3 | $0.47 | $2K | |
| ||||||
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 7,721 footnote F1 | $0.40 | $3K | |
| ||||||
 Prathyusha Duraibabu - Officer | Tax withholding / forfeiture | Common Stock | 36,676 footnote F1 | $0.40 | $15K | |
| ||||||
| Scott B. Willoughby - Officer | Tax withholding / forfeiture | Common Stock | 36,676 footnote F1 | $0.40 | $15K | |
| ||||||
| Sandy Macrae - Officer | Tax withholding / forfeiture | Common Stock | 102,950 footnote F1 | $0.40 | $41K | |
| ||||||
| Gregory D. Davis - Officer | Tax withholding / forfeiture | Common Stock | 7,721 footnote F1 | $0.40 | $3K | |
| ||||||
| Nathalie Dubois-Stringfellow - Officer | Tax withholding / forfeiture | Common Stock | 36,676 footnote F1 | $0.40 | $15K | |
| ||||||
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 578 footnote F1 | $0.42 | $241 | |
| ||||||
| Gregory D. Davis - Officer | Tax withholding / forfeiture | Common Stock | 723 footnote F1 | $0.42 | $301 | |
| ||||||
| Nathalie Dubois-Stringfellow - Officer | Tax withholding / forfeiture | Common Stock | 2,544 footnote F1 | $0.42 | $1K | |
| ||||||
| Scott B. Willoughby - Officer | Tax withholding / forfeiture | Common Stock | 2,035 footnote F1 | $0.42 | $848 | |
| ||||||
| Prathyusha Duraibabu - Officer | Tax withholding / forfeiture | Common Stock | 2,544 footnote F1 | $0.42 | $1K | |
| ||||||
| Sandy Macrae - Officer | Tax withholding / forfeiture | Common Stock | 7,488 footnote F1 | $0.42 | $3K | |
| ||||||
| Nikunj Jain - Officer | Tax withholding / forfeiture | Common Stock | 6,708 footnote F1 | $0.66 | $4K | |
| ||||||
Item 1.03, 2.01, 9.01
Item 1.03, 2.01, 7.01, 9.01
Item 1.01, 1.03, 9.01
Item 8.01, 9.01
Recent SGMO Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
SGMO insider trading FAQ
What is the latest insider trade for SGMO?
SANGAMO THERAPEUTICS, INC (SGMO) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-27. The full record for SGMO runs to 68 Form 4 filings, the earliest from 2024-11-26. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SGMO stock?
No insider purchases of SGMO were filed in the last 90 days.
How many insiders are selling SGMO stock?
No insider sales of SGMO were filed in the last 90 days. 2 sales are on record for this company.
Where can I see SGMO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SGMO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gregory D. Davis view on EDGAR
- - Nikunj Jain view on EDGAR
- - Nathalie Dubois-Stringfellow view on EDGAR
- - Scott B. Willoughby view on EDGAR
- - Sandy Macrae view on EDGAR
- - Gregory D. Davis view on EDGAR
- - Nathalie Dubois-Stringfellow view on EDGAR
- - Nathalie Dubois-Stringfellow view on EDGAR
- - Nikunj Jain view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where SGMO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SGMO with a 7-day demo
- SGMO on your watchlist
- Every SGMO Form 4 filing on record
- Up to 3 months of SGMO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
